Welcome to our dedicated page for Cardinal Health SEC filings (Ticker: CAH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Cardinal Health, Inc. (NYSE: CAH) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Cardinal Health is an Ohio corporation whose common shares trade on the New York Stock Exchange under the symbol CAH, as noted in multiple Form 8-K filings. These documents give investors detailed insight into the company’s financial condition, governance, capital structure, and material events.
Cardinal Health regularly files Form 8-K current reports to announce significant developments. Recent 8-K filings include disclosures about quarterly and annual financial results, updates to fiscal 2026 non-GAAP earnings per share outlook, entry into material definitive agreements such as credit facilities and receivables purchase amendments, public offerings of notes to help fund acquisitions like Solaris Health, and the completion of those offerings. Other 8-Ks document matters such as the 2025 Annual Meeting of Shareholders and voting results on director elections, say-on-pay, and auditor ratification.
The company’s definitive proxy statement on Schedule 14A (DEF 14A) offers extensive information on corporate governance, Board composition, executive compensation, and shareholder voting items. Cardinal Health’s proxy materials describe its strategic priorities, fiscal performance highlights, Board skills and refreshment, and engagement with shareholders.
Through Stock Titan, users can review Cardinal Health’s periodic and current reports and use AI-powered tools to summarize key points from lengthy filings. These tools help explain complex sections, highlight items such as non-GAAP metrics definitions, capital markets transactions, and credit agreements, and make it easier to track themes like Specialty growth, distribution network investments, and capital allocation. The filings page also surfaces relevant exhibits, including indentures, underwriting agreements, and amendments to financing arrangements, giving a structured view of Cardinal Health’s obligations and governance framework.
BlackRock Portfolio Management LLC has filed an amended Schedule 13G reporting its beneficial ownership in Cardinal Health, Inc. common stock. As of the event date, it beneficially owned 9,141,796 shares, representing 3.8% of the outstanding common stock. The firm has sole voting power over 8,465,682 shares and sole dispositive power over 9,141,796 shares, with no shared voting or dispositive power reported.
The filing states that various persons have rights to receive dividends or sale proceeds from these shares, but no single person has more than five percent of the total outstanding common shares of Cardinal Health. BlackRock Portfolio Management LLC certifies that the shares were acquired and are held in the ordinary course of business and not for the purpose or effect of changing or influencing control of Cardinal Health.
Cardinal Health Chief Human Resources Officer receives equity grant
Cardinal Health’s Chief Human Resources Officer, Valerie Christine Pitteroff, acquired 3,982 common shares on January 15, 2026, reported as an acquisition at a reference price of $213.26 per share. The footnotes explain this is a grant of restricted share units that will vest in three equal annual installments beginning on August 15, 2027, meaning the shares are subject to time-based vesting conditions.
After this grant, she beneficially owns 8,022 common shares directly and 463 common shares indirectly through a 401(k) plan. The filing does not report any sales of Cardinal Health stock, only this new award and updated beneficial ownership totals.
Cardinal Health, Inc. reported that it has updated its previously issued fiscal year 2026 non-GAAP earnings per share outlook. This means the company has revised its internal expectations for how much profit per share it plans to generate, after adjusting for certain items.
The company also highlighted its upcoming appearance at the 44th Annual J.P. Morgan Healthcare Conference, scheduled for January 13 at 9:00 a.m. Pacific Standard Time. Additional details are provided in a news release issued on January 13, 2026 and attached as an exhibit.
Cardinal Health Inc. (CAH) reported the initial share ownership of its Chief Human Resources Officer, Valerie Christine Pitteroff, in a Form 3 filing. She beneficially owns 4,040 Common Shares directly. In addition, she has an indirect interest in 463 Common Shares held through a 401(k) plan. This filing establishes her baseline ownership position as an officer of the company and does not reflect any new purchase or sale transactions.
Cardinal Health Inc. reported an insider equity transaction by its Chief Legal/Compliance Officer. On 12/01/2025, the officer had 422 common shares disposed of in a transaction coded "F," which represents shares withheld to cover tax obligations related to restricted share units. The price used for the withholding was the closing share price of
After this tax withholding event and an adjustment for shares transferred under a domestic relations order, the officer beneficially owned 34,427 common shares directly. The filing notes that these share withholdings are administrative in nature and tied to equity compensation rather than an open-market sale.
Cardinal Health reported a routine insider transaction by the CEO of its PSS segment. On 12/01/2025, 551 common shares of Cardinal Health were withheld at a price of $212.26 per share to cover the executive’s tax obligations related to restricted share units. After this tax withholding, the reporting person directly beneficially owns 52,877 common shares of Cardinal Health.
Cardinal Health Inc. reported an insider share transaction by its Chief Accounting Officer. On 12/01/2025, the officer had 61 common shares withheld and disposed of to cover tax obligations related to restricted share units, at a reference price of $212.26 per share. After this tax-related withholding, the officer beneficially owned 3,495 Cardinal Health common shares directly. The filing is administrative in nature and reflects routine equity compensation and associated tax withholding.
Cardinal Health Inc. executive reports routine share withholding for taxes. The CEO of the GMPD segment filed a Form 4 reporting that on 12/01/2025, 595 Cardinal Health common shares were withheld at a price of $212.26 per share to cover tax obligations related to restricted share units. After this transaction, the reporting person beneficially owned 25,490 common shares directly. The filing notes that this was a non-open-market transaction classified under code "F," meaning it reflects shares withheld by the company rather than a discretionary sale in the market.
Cardinal Health (CAH) disclosed a director equity grant on a Form 4. On 11/05/2025, a director acquired 1,067 restricted share units (Transaction Code A) at a stated price of $0. These RSUs will vest on November 5, 2026, or on the date of the 2026 Annual Meeting of Shareholders if that meeting occurs before November 5, 2026.
Following this award, the director beneficially owned 2,116 common shares, held directly. This filing reflects routine director compensation in equity and does not indicate an open-market purchase or sale.
Cardinal Health (CAH) reported an insider equity grant on a Form 4. A director acquired 1,067 common shares on 11/05/2025 via a restricted share unit award at $0. Following this grant, the director beneficially owns 2,116 shares, held directly.
The restricted share units will vest on November 5, 2026, or on the date of the 2026 Annual Meeting of Shareholders if that meeting occurs earlier.
FAQ
What is the current stock price of Cardinal Health (CAH)?
What is the market cap of Cardinal Health (CAH)?
